Bruker BioSpin is a leading provider of scientific instruments and analytical solutions for life science research and industry applications, employing over 5,000 people.

Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Company’s cell-free protein synthesis platform, comprising the XpressCFTM platform, exclusively licensed from Sutro Biopharma, Inc., together with Vaxcyte’s proprietary know-how, enables the design and production of protein carriers and antigens, the critical building blocks of vaccines, in ways that the Company believes conventional vaccine technologies currently cannot. In addition to its pneumococcal conjugate vaccines in development, VAX-24 and VAX-XP, Vaxcyte is leveraging its proprietary platform to advance other novel vaccines, including a prophylactic vaccine to prevent Group A Strep infections (VAX-A1) and a therapeutic vaccine to treat periodontal disease (VAX-PG).

Datavant is a healthcare data logistics company that connects and moves data securely for organizations, providing solutions for data integration and collaboration.

Dotmatics is an R&D scientific software company that specializes in connecting science, data, and decision-making. Their enterprise R&D platform and applications are designed to drive efficiency and accelerate innovation.

Teva Pharmaceuticals is a pharmaceutical company specializing in the development, production, and marketing of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients.

Ganymede is a low-code bio-aware PaaS for biotech software engineering, facilitating easy data integration and pipeline construction for software engineers in the biotech industry.

Day One Biopharmaceuticals is a biotechnology company dedicated to developing innovative cancer therapies for patients of all ages, focusing on the unique needs of both children and adults. By leveraging advances in cancer research, the company aims to bring effective treatments to market quickly for families facing cancer diagnoses, while prioritizing collaborations with research institutions and other biotech firms.